NDC 16110-915
TAZORAC
Tazarotene
TAZORAC is a Cutaneous Cream in the Human Prescription Drug category. It is labeled and distributed by Almirall, Llc. The primary component is Tazarotene.
| Product ID | 16110-915_3970edf3-64d9-4e88-9039-e92fe5a11cfb |
| NDC | 16110-915 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TAZORAC |
| Generic Name | Tazarotene |
| Dosage Form | Cream |
| Route of Administration | CUTANEOUS |
| Marketing Start Date | 2020-02-03 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021184 |
| Labeler Name | Almirall, LLC |
| Substance Name | TAZAROTENE |
| Active Ingredient Strength | 0 mg/g |
| Pharm Classes | Retinoid [EPC],Retinoids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 16110-915-30
1 TUBE in 1 CARTON (16110-915-30) > 30 g in 1 TUBE
| Marketing Start Date | 2020-02-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 16110-915-30 [16110091530]
TAZORAC CREAM
| Marketing Category | NDA |
| Application Number | NDA021184 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2020-02-03 |
NDC 16110-915-60 [16110091560]
TAZORAC CREAM
| Marketing Category | NDA |
| Application Number | NDA021184 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2020-02-03 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| TAZAROTENE | .05 mg/g |
Pharmacological Class
- Retinoid [EPC]
- Retinoids [CS]
NDC Crossover Matching brand name "TAZORAC" or generic name "Tazarotene"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0023-0042 | TAZORAC | tazarotene |
| 0023-8335 | TAZORAC | tazarotene |
| 0023-9155 | TAZORAC | tazarotene |
| 0023-9156 | TAZORAC | tazarotene |
| 16110-042 | Tazorac | tazarotene |
| 16110-833 | Tazorac | tazarotene |
| 16110-915 | TAZORAC | tazarotene |
| 16110-916 | TAZORAC | tazarotene |
| 0187-2098 | Arazlo | tazarotene |
| 0023-9236 | AVAGE | tazarotene |
| 51862-295 | FABIOR | tazarotene |
| 0168-0454 | TAZAROTENE | tazarotene |
| 0713-0670 | Tazarotene | Tazarotene |
| 0713-0764 | Tazarotene | Tazarotene |
| 0713-0804 | TAZAROTENE | tazarotene |
| 0713-0805 | TAZAROTENE | tazarotene |
| 51672-1373 | Tazarotene | Tazarotene |
| 51672-1374 | Tazarotene | Tazarotene |
| 60758-556 | Tazarotene | Tazarotene |
| 60758-561 | Tazarotene | Tazarotene |
| 68308-685 | tazarotene | tazarotene |
| 68308-745 | Tazarotene | TAZAROTENE |
| 0168-0455 | Tazarotene Cream | tazarotene |
Trademark Results [TAZORAC]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 TAZORAC 75175133 2124432 Live/Registered |
ALMIRALL, LLC 1996-09-19 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.